Latest Conference Articles

McKesson’s private brand of OTC health and wellness products are a great way for independent pharmacies to increase profits.

Emily Flaugher, Vice President and General Manager of Health Mart Atlas and Atlas Specialty at McKesson, sat down with Drug Topics to discuss McKesson solutions that help independent pharmacists maximize reimbursement.

Three posters presented at the American Diabetes Association 84th Scientific Sessions examined GLP-1 use and cardiovascular disease risk in several different patient populations.

Three posters presented at the American Diabetes Association 84th Scientific Sessions looked into the current landscape of GLP-1s.

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

Two posters presented at the American Diabetes Association 84th Scientific Sessions looked into the impact of glucagon-like peptide-1 receptor agonists in type 1 diabetes management.

Drug Topics has been on site at McKesson ideaShare this week! Check out this podcast to hear a few of the things we've experienced and what we've learned so far.

Two posters presented at the American Diabetes Association 84th Scientific Sessions looked at challenges of remote CGM in older populations and after discharge from the hospital.

During a session at McKesson ideaShare 2024, Martin Dennis of RxOwnership was joined by digital marketing experts to discuss key marketing tools for independent pharmacies.

Access to diabetes self-management education and support services are crucial for improving diabetes outcomes.

Check out some of the latest research into diabetes medication options.

Drug Topics has been on site at McKesson ideaShare this week. Check out this podcast to hear a few of the exciting happenings at this year’s meeting.

Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.

A poster presented at AHS 2024 found that older patients tended to have more vitamin deficiencies compared to younger patients.

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.

From the Health Mart Pharmacy of the Year award presentation to general sessions covering pharmacy profitability, community impact, and much more, see what’s to come at this year’s meeting in New Orleans.

In a session presented at the 2024 Heart in Diabetes Conference, Neha Pagidipati, MD, MPH, discussed weight change and its effects on cardiovascular complications.

Two posters presented at ENDO 2024 assessed semaglutide’s impact on taste sensitivity and tirzepatide’s role in body weight reduction.

In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.

Three posters presented at ENDO 2024 focused on women’s health.

Patients with advanced cancer can experience malignant wounds, which can have a negative impact on quality of life.

In a study presented at ASCO 2024, investigators found that all 20 included patients with early stage breast cancer receiving chemotherapy developed hyperglycemia.

Researchers addressed the use of cannabis to treat cancer symptoms in rural and urban areas, as well as patients’ comfortability discussing it with their providers.

In a session presented at the 2024 Heart in Diabetes Conference, researchers discussed the abilities of continuous glucose monitoring (CGM) to capture lifestyle data and improve mortality rates.

Vaccinated men and women are at a reduced risk for HPV-related cancers, according to research presented at ASCO 2024.

In an abstract presented at ENDO 2024, researchers addressed practitioners’ current knowledge of CGM and their experience prescribing in low-income communities.

HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.